Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04920097 · ClinicalTrials.gov registry record · NA
Auricular Point Acupressure to Manage Chemotherapy Induced Neuropathy
A NA study of Chemotherapy-induced Neuropathy, sponsored by The University of Texas Health Science Center, Houston.
- Active
- Registry status
- NA
- Development phase
- 225
- Enrollment target
- 2
- Study locations
NCT04920097 is a NA study of Chemotherapy-induced Neuropathy that is active but no longer recruiting, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 225 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT04920097, a NA study of Chemotherapy-induced Neuropathy, is active but no longer recruiting, sponsored by The University of Texas Health Science Center, Houston.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 225 participants
- Enrollment target
- 2
- Study locations
Study Summary
The proposed randomized control trial will evaluate auricular point acupressure (APA) on chemotherapy-induced neuropathy (CIN), rigorously considering point specificity and placebo effects by integrating self-report measures, psychophysical measures (QST), endogenous biomarkers (cytokines), and neuro-imaging to investigate APA's efficacy and underlying mechanism(s).
Conditions Studied
Interventions
- OTHER Usual Care
- OTHER In-person training for seed placement and APA
- OTHER Virtual training for seed placement and APA
- OTHER Post-training zoom session for seed placement and APA coaching
Study Locations (2)
Maryland
- Johns Hopkins University - Baltimore
Texas
- The University of Texas Health Science Center at Houston - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 225 participants |
| Start Date | 2021-07-08 |
| Est. Completion | 2026-05-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04920097
The ClinicalTrials.gov registry entry for NCT04920097 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 225 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chemotherapy-induced Neuropathy appearing as the primary indexed condition, and to 4 interventions - of which Usual Care is the first listed.
NCT04920097 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Maryland, Texas.
Frequently Asked Questions
What is clinical trial NCT04920097 about?
NCT04920097 is a clinical study titled "Auricular Point Acupressure to Manage Chemotherapy Induced Neuropathy". The proposed randomized control trial will evaluate auricular point acupressure (APA) on chemotherapy-induced neuropathy (CIN), rigorously considering point specificity and placebo effects by integrating self-report measures, psychophysical measures (QST), endogenous biomarkers (cytokines), and neur...
What is the current status of trial NCT04920097?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 225 participants. The study started on 2021-07-08. Estimated completion is 2026-05-30.
What conditions does trial NCT04920097 study?
This clinical trial studies the following conditions: Chemotherapy-induced Neuropathy.
What interventions are being tested in trial NCT04920097?
The interventions under investigation include: Usual Care (OTHER), In-person training for seed placement and APA (OTHER), Virtual training for seed placement and APA (OTHER), Post-training zoom session for seed placement and APA coaching (OTHER).
Who is sponsoring clinical trial NCT04920097?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04920097 being conducted?
This trial has 2 study locations across Maryland, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chemotherapy-induced Neuropathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.